Anti-Catechol O-methyltransferase/COMT Antibody

Research Sub Category
Neurotransmitters & Receptors

Immunohistochemistry Analysis: A 1:2,000 dilution from a representative lot detected Catechol O-methyltransferase/COMT in human prostate cancer, normal liver and kidney tissue sections.

Research Category
Neuroscience

This Anti-Catechol O-methyltransferase Antibody is validated for use in Western Blotting, Immunohistochemistry for the detection of COMT.

Evaluated by Western Blotting in human fetal liver tissue lysate.

Western Blotting Analysis: 0.2 µg/mL of this antibody detected Catechol O-methyltransferase/COMT in 10 µg of human fetal liver tissue lysate.

This polyclonal antibody was raised against a sequence present in both the membrane-bound (MB-COMT) and the soluble (S-COMT) spliced isoforms of human catechol O-methyltransferase reported by UniProt (P21964).

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Catechol O-methyltransferase (EC 2.1.1.6; UniProt P21964) is encoded by the COMT gene (Gene ID 1312) in human. Catechol-O-methyltransferase initiates the metabolic breakdown of catecholamines (including the neurotransmitters dopamine, epinephrine, and norepinephrine) by catalyzing the transfer of a methyl group from S-adenosylmethionine (SAM) to catecholamines in the presence Mg++. This O-methylation results in one of the major degradative pathways of the catecholamine transmitters. In addition to endogenous substances, COMT is also important in the metabolism of catechol drugs. Two isoforms exist as a result of alternative initiation codon usage. The membrane-bound isoform or MB-COMT contains a short N-terminal cytoplasmic tail (a.a. 1-6), a transmembrane segment (a.a. 7-26), and a large C-terminal extracellular region (a.a. 27-271), while the soluble or S-COMT isoform lacks the N-terminal 50-amino acid sequence of MB-COMT. MB-COMT and S-COMT differ in their substrate affinity and capacities. Despite having a lower capacity than S-COMT, MB-COMT has around a 10-fold greater affinity for dopamine and noradrenaline, and therefore is likely to be better suited for metabolizing catecholamines at the concentrations found in brain. The influence of the Val(158)Met polymorphic form of catechol-o-methyltransferase (COMT) on brain activation and functional connectivity is the subject of numerous studies.

~28 kDa observed. 30.04 kDa (human MB-COMT) and 24.45 kDa (human S-COMT) calculated. Uncharacterized band(s) may appear in some lysates.

Epitope: Extracellular domain.

KLH-conjugated linear peptide corresponding to an extracellular domain sequence of human catechol O-methyltransferase.

Concentration: Please refer to lot specific datasheet.

Replaces: AB5873

Affinity purified.

Purified rabbit polyclonal antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.

Stable for 1 year at 2-8°C from date of receipt.